Marshall Wace North America’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,896	Closed	-$663K	–	1479
2020 Q3	$663K	Buy	+6,896	New	+$798K	﹤0.01%	904
2020 Q2	–	Sell	-2,149	Closed	-$186K	–	1357
2020 Q1	$186K	Buy	2,149 +573	+36%	+$56.1K	﹤0.01%	905
2019 Q4	$169K	Sell	1,576 -134,365	-99%	-$14.1M	﹤0.01%	1000
2019 Q3	$12.3M	Buy	+135,941	New	+$12.7M	0.07%	231
2019 Q2	–	Sell	-580,904	Closed	-$51.2M	–	1446
2019 Q1	$51.2M	Buy	580,904 +264,402	+84%	+$22.1M	0.36%	82
2018 Q4	$22.6M	Sell	316,502 -158,938	-33%	-$15.2M	0.22%	97
2018 Q3	$58.5M	Sell	475,440 -127,535	-21%	-$14.5M	0.4%	63
2018 Q2	$59.2M	Buy	602,975 +164,189	+37%	+$14.7M	0.33%	68
2018 Q1	$36.4M	Sell	438,786 -115,402	-21%	-$9.75M	0.18%	132
2017 Q4	$43M	Sell	554,188 -160,280	-22%	-$10.9M	0.24%	95
2017 Q3	$43.6M	Buy	714,468 +152,128	+27%	+$8.03M	0.28%	85
2017 Q2	$25.9M	Sell	562,340 -249,540	-31%	-$12.1M	0.19%	139
2017 Q1	$34.9M	Buy	+811,880	New	+$34.8M	0.28%	104